What does the FDA really say about diversity in clinical trials? What do you need to do now to make sure you remain compliant? Our white paper, answers these questions and more, giving you the insight you need to successfully run a compliant, diverse study.
Related Reading
Resource / Health Equity
Recruiting and Retaining Diverse Clinical Research Participants – Member Best Practices
July 25, 2024
AdvaMed is engaged in efforts to ensure our industry is doing its part to mitigate the adverse impacts of health disparities among people and communities of color.
Blog / Health Equity
Racial and Gender Equity in Health Care: a Wake-up Call and an Opportunity
July 8, 2024
Two important developments just happened on the health equity and diversity front.
One, the American Heart Association released a ground-breaking study finding women’s cardiovascular health is perhaps more poorly understood than even those of us working in health equity realized. The study also pointed out how women face unique-to-gender threats to their cardiovascular health at key life stages, such as during pregnancy and menopause. For example, the study cites findings from the Centers for Disease Control and Prevention that cardiac and coronary conditions are a leading cause of preventable maternal deaths (13 percent).
News / Health Equity
NEW EPISODE: Medtech POV with Scott Whitaker | American Heart Association CEO Nancy Brown on the Evolution of Cardiovascular Care, Important Role of Medical Technology
June 17, 2024
In the latest episode of Medtech POV, Nancy Brown, Chief Executive Officer of the American Heart Association, joins host Scott Whitaker to talk about her journey to leading one of the most influential health care organizations in the world, the 100-year history of the Association, and how medtech innovation has improved health outcomes for millions living with cardiovascular diseases and stroke.
Blog / Health Equity
Prioritizing Heart Health in Women Across the Health System
May 23, 2024
Heart disease is the leading cause of death for both men and women in the United States, but historically—and even today—women are underrepresented in heart disease research, can be overlooked in the clinical care setting when it comes to cardiovascular care, and too many women in the United States (44%) do not recognize heart disease as their number one killer.
Health Equity
Women’s Health Equity Initiative
AdvaMed is dedicated to ensuring our industry focuses their efforts on treating and raising the awareness of women’s health conditions.
Resource / Health Equity
Phase III: Disparities in Access to Selected Advanced Medical Procedures in the Medicare Population
March 6, 2024
The final report of a three-part series investigates the prevalence of racial and ethnic disparities in the use of in the use of advanced interventions in the Medicare program.
Resource / Health Equity
Phase II: Literature Review: Racial Disparities in Use of Selected Medical Technologies
March 6, 2024
The second of a three-phase research series examines the difference in access to certain advanced interventions, including a range of surgical, medical and technological interventions.
Resource / Health Equity
Phase I: Disparities in Access to Advanced Medical Procedures in the Medicare Population
March 6, 2024
Racial and ethnic healthcare disparities in access to advanced interventions have persisted in the U.S. medical system. The first of a three-phase research series examines the difference in access to certain advanced interventions.